| Title | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I |
| ToC Doc | Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I |
| Docket Number | 2022-00713 |
| Type | Proposed Rule |
| Subject | Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I |
| Publication Date | 2022-01-14 |
| Last Updated Date | 2022-01-13 08:15:21 -0500 |
| Last Public Inspection | 2022-01-13 |
| Filed At | 2022-01-13T08:45:00.000-05:00 |
| 2022-00713_PI.pdf (169423 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 25 |
| Filing Type | regular |
| Agencies | Drug Enforcement Administration |
You can find the raw source document below...